Search research articles
Contact Us
Filters
Showing results (91-100 of 207) with videos related to
Page
of 21
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation
|
May 1, 1983
Determination of adrenoceptors of the alpha 2-subtype on isolated human fat cells
P Engfeldt, P Arner, H Kimura, et al.
European Journal of Clinical Investigation
|
October 1, 1984
Influence of fasting on lipolytic response to adrenergic agonists and on adrenergic receptors in subcutaneous adipocytes
J Ostman, P Arner, H Kimura, et al.
International Journal of Obesity
|
January 1, 1981
Regulation of lipolysis in hyperthyroidism
J Ostman, P Arner, J Bolinder, et al.
European Journal of Pharmacology
|
January 27, 1988
Adrenoceptor occupancy in isolated human fat cells and its relationship with lipolysis rate
P Arner, J Hellmér, A Wennlund, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1980
Dialysis and renal transplantation in end-stage diabetic nephropathy. A survey
G Lundgren, C Groth, R Gunnarsson, et al.
The Journal of Clinical Investigation
|
March 1, 1984
Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion
P Arner, J Bolinder, P Engfeldt, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1982
Phosphodiesterase activity in human subcutaneous adipose tissue in hyper- and hypothyroidism
P Engfeldt, P Arner, J Bolinder, et al.
The Journal of Diabetic Complications
|
January 1, 1991
Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus
S Sjöberg, M Gjötterberg, L Berglund, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1986
Adrenergic regulation of lipolysis in human adipocytes: findings in hyper- and hypothyroidism
H Wahrenberg, P Engfeldt, P Arner, et al.
Lakartidningen
|
July 10, 1991
[A consensus in Europe--general targets and a 5-year program: the Saint Vincent declaration for better diabetic care]
U Adamson, A Ericsson, Y Larsson, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 207) with videos related to
Sort By:
Page
of 21
Scandinavian Journal of Clinical and Laboratory Investigation
|
May 1, 1983
Determination of adrenoceptors of the alpha 2-subtype on isolated human fat cells
P Engfeldt, P Arner, H Kimura, et al.
European Journal of Clinical Investigation
|
October 1, 1984
Influence of fasting on lipolytic response to adrenergic agonists and on adrenergic receptors in subcutaneous adipocytes
J Ostman, P Arner, H Kimura, et al.
International Journal of Obesity
|
January 1, 1981
Regulation of lipolysis in hyperthyroidism
J Ostman, P Arner, J Bolinder, et al.
European Journal of Pharmacology
|
January 27, 1988
Adrenoceptor occupancy in isolated human fat cells and its relationship with lipolysis rate
P Arner, J Hellmér, A Wennlund, et al.
Acta Medica Scandinavica. Supplementum
|
January 1, 1980
Dialysis and renal transplantation in end-stage diabetic nephropathy. A survey
G Lundgren, C Groth, R Gunnarsson, et al.
The Journal of Clinical Investigation
|
March 1, 1984
Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion
P Arner, J Bolinder, P Engfeldt, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 1, 1982
Phosphodiesterase activity in human subcutaneous adipose tissue in hyper- and hypothyroidism
P Engfeldt, P Arner, J Bolinder, et al.
The Journal of Diabetic Complications
|
January 1, 1991
Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus
S Sjöberg, M Gjötterberg, L Berglund, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1986
Adrenergic regulation of lipolysis in human adipocytes: findings in hyper- and hypothyroidism
H Wahrenberg, P Engfeldt, P Arner, et al.
Lakartidningen
|
July 10, 1991
[A consensus in Europe--general targets and a 5-year program: the Saint Vincent declaration for better diabetic care]
U Adamson, A Ericsson, Y Larsson, et al.
Page
of 21